key: cord-0710590-a1w5e6v2 authors: DeBolt, Chelsea A.; Bianco, Angela; Limaye, Meghana A.; Silverstein, Jenna; Penfield, Christina A.; Roman, Ashley S.; Rosenberg, Henri M.; Ferrara, Lauren; Lambert, Calvin; Khoury, Rasha; Bernstein, Peter S.; Burd, Julia; Berghella, Vincenzo; Kaplowitz, Elianna; Overbey, Jessica R.; Stone, Joanne title: Pregnant women with severe or critical COVID-19 have increased composite morbidity compared to non-pregnant matched controls date: 2020-11-20 journal: Am J Obstet Gynecol DOI: 10.1016/j.ajog.2020.11.022 sha: cea333e1fc7fb4ca0efc936c3690d107dc8e2a44 doc_id: 710590 cord_uid: a1w5e6v2 Background In March 2020, as community spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) became increasingly prevalent, pregnant women appeared to be equally susceptible to developing Coronavirus Disease 2019 (COVID-19). While the disease course usually appears mild, severe and critical COVID-19 appears to lead to significant morbidity including ICU admission with prolonged hospital stay, intubation, mechanical ventilation and even death. Although there are recent reports regarding the impact of COVID-19 on pregnancy, information regarding the severity of COVID-19 in pregnant versus non-pregnant women remains unknown. Objective We aim to describe the outcomes of severe and critical COVID-19 infection in pregnant versus non-pregnant reproductive aged women. Study Design This is a multi-center retrospective case-control study of women with laboratory confirmed SARS-CoV-2 infection hospitalized with severe or critical COVID-19 in four academic medical centers in NYC and one in Philadelphia between March 12 and May 5, 2020. The cases consist of pregnant women admitted specifically for severe or critical COVID-19 and not for obstetric indication. The controls consist of reproductive aged, non-pregnant women admitted for severe or critical COVID-19. The primary outcome is a composite morbidity including: death, need for intubation, extracorporeal membrane oxygenation (ECMO), non-invasive positive pressure ventilation or need for high flow nasal cannula oxygen supplementation. Secondary outcomes include ICU admission, length of stay, need for discharge to long term acute care facility and discharge with home oxygen requirement. Results Thirty-eight pregnant women with SARS-CoV-2 polymerase chain reaction (PCR) confirmed infection were admitted to five institutions specifically for COVID-19, 29 (76.3%) meeting criteria for severe disease and 9 (23.7%) meeting criteria for critical disease. The mean age and BMI were significantly higher in the non-pregnant control group. The non-pregnant cohort was also noted to have increased frequency of pre-existing medical comorbidities, including diabetes, hypertension and coronary artery disease. Pregnant women were more likely to experience the primary outcome when compared to the non-pregnant control group (34.2% vs. 14.9%, p=0.03, adjusted OR 4.6 [95% CI 1.2-18.2]). Pregnant patients experienced higher rates of ICU admission (39.5% vs. 17.0%, p<0.01, adjusted OR 5.2 [95% CI 1.5-17.5]). Among pregnant women that underwent delivery, 72.7% occurred via cesarean delivery and mean gestational age at delivery was 33.8 ±5.5 weeks in patients with severe disease and 35 ±3.5 weeks in patients with critical COVID-19. Conclusions Pregnant women with severe and/or critical COVID-19 are at increased risk for certain morbidities when compared to non-pregnant controls. Despite the higher comorbidities of diabetes and hypertension in the non-pregnant controls, the pregnant cases were at increased risk for composite morbidity, intubation, mechanical ventilation and ICU admission. These findings suggest that pregnancy may be associated with a worse outcome in women with severe and critical COVID-19. Our study suggests that similar to other viral infections such as SARS-CoV and MERS-CoV, pregnant women may be at risk for greater morbidity and disease severity. This study adds to existing data by comparing the clinical characteristics and 53 outcomes of severe and critical COVID-19 in pregnant and non-pregnant women. 54 Our data suggest that the clinical course and severity of COVID-19 in 55 hospitalized pregnant women is worse than non-pregnant controls. non-pregnant controls. While, it is well documented that persons of non-White race 400 have worse outcomes, there was no statistically significant difference in distribution of 401 race and ethnicity between our two cohorts. We are unable to comment on differences 402 in race and ethnicity in our current study and how this difference has impacted the 403 primary outcome. This data is either not reported or reported as "other" or "unknown" for Coronavirus Disease (COVID-19) Situation Report 209 Coronavirus disease 2019 460 infection among asymptomatic and symptomatic pregnant women: two weeks of 461 confirmed presentations to an affiliated pair of New York City hospitals Characteristics of and Important Lessons From the 464 COVID-19) Outbreak in China: Summary of a Report of 465 72 314 Cases From the Chinese Center for Disease Control and Prevention Risk factors associated with the increasing prevalence of 469 pneumonia during pregnancy Complement associated microvascular injury 472 and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five 473 cases Emerging infections and pregnancy Asthma in pregnancy Coronavirus disease 2019 (COVID-19) 479 pandemic and pregnancy Characteristics of Women of Reproductive Age 482 with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -United States A case-controlled study comparing clinical 486 course and outcomes of pregnant and non-pregnant women with severe acute 487 respiratory syndrome Middle East 490 Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases 491 From Saudi Arabia Pregnancy and perinatal outcomes of 493 women with severe acute respiratory syndrome Epidemiology Working Group for NCIP Epidemic Response Disease Control and Prevention Estimating clinical severity of COVID-19 from 502 the transmission dynamics in Wuhan, China SMFM Consult Series #47: Sepsis during 506 pregnancy and the puerperium Defining acute renal failure Acute liver failure A comorbidity-based screening tool to 513 predict severe maternal morbidity at the time of delivery American College of Obstetricians and Gynecologists and the Society for Maternal-516 Severe maternal morbidity: screening and 517 review Coronavirus disease 2019 in pregnant women: a report 519 based on 116 cases Public Health Agency of Sweden's Brief 522 Report: Pregnant and postpartum women with severe acute respiratory syndrome 523 coronavirus 2 infection in intensive care in Sweden Intensive care unit admissions for 526 pregnant and nonpregnant women with coronavirus disease 2019 Coronavirus 529 Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know Prevalence of comorbidities in the novel Wuhan 532 coronavirus (COVID-19) infection: a systematic review and meta-analysis Clinical features of patients infected with 2019 novel 535 coronavirus in Wuhan, China Clinical course and risk factors for mortality of adult 538 inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical Characteristics of Coronavirus Disease 2019 543 in China Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-546 2) Infection at Five New York City Medical Centers Clinical characteristics of 46 pregnant 549 women with a severe acute respiratory syndrome coronavirus 2 infection in Washington 550 Maternal deaths with 553 coronavirus disease 2019: a different outcome from low-to middle-resource countries Maternal death due to 556 COVID-19 Clinical manifestations, risk factors, and 559 maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living 560 systematic review and meta-analysis Coronavirus disease 2019 during 563 pregnancy: a systematic review of reported cases Outcome of coronavirus spectrum 566 infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta *ICU length of stay is only calculated for those 12 patients who were admitted to the ICU (6 pregnant 649 cases and 6 non-pregnant controls) Hospital length of stay was log transformed and modeled using linear regression. The beta coefficient 651 for cases was exponentiated to estimate the ratio of geometric means *NICU length of stay is only calculated for those 8 of the 12 neonates who were admitted to the NICU who had both 687 NICU admission and discharge date